The shares disposed of were originally granted as restricted stock units and were sold to meet tax obligations related to their vesting. With the company's next earnings report scheduled for February 6, 2025, investors seeking deeper insights can access comprehensive analysis and additional ProTips through InvestingPro's detailed research reports, which provide expert analysis on over 1,400 US stocks. With the company's next earnings report scheduled for February 6, 2025, investors seeking deeper insights can access comprehensive analysis and additional ProTips through InvestingPro's detailed research reports, which provide expert analysis on over 1,400 US stocks. The shares disposed of were originally granted as restricted stock units and were sold to meet tax obligations related to their vesting.
In other recent news, Canopy Growth (NASDAQ:CGC) Corporation has reported a mix of financial outcomes in its Q2 FY2025 results. The company's consolidated net revenue experienced a 9% decrease year-over-year, amounting to CAD 63 million. However, when excluding divested businesses, revenue saw a 3% increase. An improvement was seen in gross margins, rising to 35%, and adjusted EBITDA losses narrowed to CAD 6 million.
The company's Storz & Bickel device business and Canadian medical cannabis segment reported strong revenue growth, while the adult-use segment saw a decline. In recent developments, Canopy Growth completed acquisitions of Wana and Jetty and is on track to finalize the Acreage acquisition. Despite a drop in adult-use business revenue, partly due to supply interruptions of Wana edibles, the company aims to enhance its adult-use offerings and expand in the U.S. market.
In light of recent acquisitions and product launches, Canopy Growth anticipates significant growth and plans to improve profitability in the second half of FY2025 through new product innovations.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.